BlackRock Investment Management
PBYI icon

BlackRock Investment Management’s Puma Biotechnology PBYI Stock Holding History

BlackRock Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.19M Buy
103,996
+11,401
+12% +$493K ﹤0.01% 1885
2016
Q3 		$6.21M Buy
92,595
+1,091
+1% +$55.2K 0.01% 1332
2016
Q2 		$2.73M Buy
91,504
+81,963
+859% +$2.56M ﹤0.01% 1872
2016
Q1 		$280K Sell
9,541
-2,634
-22% -$119K ﹤0.01% 3091
2015
Q4 		$955K Sell
12,175
-2,899
-19% -$228K ﹤0.01% 2632
2015
Q3 		$1.14M Sell
15,074
-11,093
-42% -$1.05M ﹤0.01% 2511
2015
Q2 		$3.06M Sell
26,167
-50,459
-66% -$9.14M ﹤0.01% 1892
2015
Q1 		$18.1M Buy
76,626
+1,832
+2% +$392K 0.02% 613
2014
Q4 		$14.2M Sell
74,794
-1,484
-2% -$329K 0.02% 725
2014
Q3 		$18.2M Sell
76,278
-1,356
-2% -$278K 0.03% 567
2014
Q2 		$5.12M Buy
77,634
+13,414
+21% +$954K 0.01% 1370
2014
Q1 		$6.69M Buy
64,220
+3,364
+6% +$395K 0.01% 1173
2013
Q4 		$6.3M Sell
60,856
-1,546
-2% -$90.7K 0.01% 1193
2013
Q3 		$3.35M Buy
62,402
+4,164
+7% +$224K 0.01% 1571
2013
Q2 		$2.58M Buy
+58,238
New +$2.05M ﹤0.01% 1672

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Investors US
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BlackRock Investment Management's PBYI Position: Q4 2016 in Review

BlackRock Investment Management increased its Puma Biotechnology (PBYI) stake by 12% in Q4 2016, buying an estimated $493K and bringing the position to 103,996 shares worth $3.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1885.

BlackRock Investment Management first reported a position in PBYI in Q2 2013 and has held it in 15 quarters since. The position peaked at $18.2M in Q3 2014. 128 funds tracked by Wall St. Rank hold PBYI as of Q4 2016.

  • BlackRock Investment Management held 103,996 shares of Puma Biotechnology worth $3.19M as of Q4 2016.
  • BlackRock Investment Management bought 11,401 Puma Biotechnology shares in Q4 2016, an estimated $493K.
  • Puma Biotechnology made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1885 holding.
  • BlackRock Investment Management first reported a position in Puma Biotechnology in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Puma Biotechnology position peaked at $18.2M in Q3 2014.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.